Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Fey

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemiaB U Mueller, A U Buerger, M Solenthaler, et al.
Leukemia & Lymphoma|April 30, 1999
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's diseaseB Bättig, E Mueller-Garamvoelgyi, S B Cogliatti, et al.
Leukemia|March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1M Jenal, J Batliner, V A Reddy, et al.
The Journal of Clinical Investigation|May 1, 1992
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probeM F Fey, H J Peter, H L Hinds, et al.
Journal of the National Cancer Institute|September 24, 1999
Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cellsU Hasse, M Tinguely, E O Leibundgut, et al.
European Journal of Haematology|October 24, 1997
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK)A Lohri, B van Hille, M Bacchi, et al.
Oncogene|June 4, 2008
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic functionA Britschgi, E Trinh, M Rizzi, et al.
Cancer Research|September 15, 1999
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysisU R Peters, M P Tschan, K A Kreuzer, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
British Journal of Haematology|September 1, 1993
Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemiaF Joncourt, A Oberli, S M Redmond, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemiaB U Mueller, A U Buerger, M Solenthaler, et al.
Leukemia & Lymphoma|April 30, 1999
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's diseaseB Bättig, E Mueller-Garamvoelgyi, S B Cogliatti, et al.
Leukemia|March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1M Jenal, J Batliner, V A Reddy, et al.
The Journal of Clinical Investigation|May 1, 1992
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probeM F Fey, H J Peter, H L Hinds, et al.
Journal of the National Cancer Institute|September 24, 1999
Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cellsU Hasse, M Tinguely, E O Leibundgut, et al.
European Journal of Haematology|October 24, 1997
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK)A Lohri, B van Hille, M Bacchi, et al.
Oncogene|June 4, 2008
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic functionA Britschgi, E Trinh, M Rizzi, et al.
Cancer Research|September 15, 1999
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysisU R Peters, M P Tschan, K A Kreuzer, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
British Journal of Haematology|September 1, 1993
Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemiaF Joncourt, A Oberli, S M Redmond, et al.
Pageof 17